Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Enveric Biosciences Inc (ENVB)

Enveric Biosciences Inc (ENVB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 41,069
  • Shares Outstanding, K 21,390
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,860 K
  • 60-Month Beta 1.76
  • Price/Sales -2.30
  • Price/Cash Flow N/A
  • Price/Book 2.07
Trade ENVB with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.92
  • Growth Rate Est. (year over year) +52,131.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8100 +5.52%
on 07/19/21
2.6900 -29.00%
on 06/29/21
-0.2600 (-11.98%)
since 06/25/21
3-Month
1.8100 +5.52%
on 07/19/21
3.1500 -39.37%
on 05/21/21
-0.5200 (-21.40%)
since 04/26/21
52-Week
1.8100 +5.52%
on 07/19/21
15.0400 -87.30%
on 12/28/20
-5.3300 (-73.62%)
since 07/24/20

Most Recent Stories

More News
Enveric Bio's Acquisition of MagicMed Accentuates Strengths of Each Company

Whitefish, Montana--(Newsfile Corp. - July 12, 2021) -   (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries,...

ENVB : 1.9100 (-0.52%)
CNFN : 0.1388 (+26.18%)
Enveric Biosciences Announces Approval from Israel's Ministry of Health to Begin its Phase 1/2 Trial of Triple-Combination CBD Treatment for Glioblastoma

/PRNewswire/ --  (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, announced today that...

ENVB : 1.9100 (-0.52%)
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates ARPO, ALTA, ENVB, FBNC, MCF; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

ARPO : 2.12 (+2.42%)
ALTA : 40.51 (+0.77%)
ENVB : 1.9100 (-0.52%)
FBNC : 38.69 (+1.04%)
MCF : 3.94 (+3.96%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Enveric Biosciences, Inc. - ENVB

/PRNewswire/ --

ENVB : 1.9100 (-0.52%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, FMBI, SWN, ENVB, MLND; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CNST : 33.99 (+0.06%)
FMBI : 17.97 (+0.73%)
SWN : 5.18 (+6.58%)
ENVB : 1.9100 (-0.52%)
MLND : 1.0600 (-5.36%)
Lifshitz Law Firm, P.C. Announces Investigation of CLDR, DTRCD, DCRN, ENVB, PACX, SNX, XERS, and SBBP

/PRNewswire/ --

CLDR : 15.86 (+0.25%)
DTRCD : 5.6500 (-2.85%)
DCRN : 9.86 (unch)
ENVB : 1.9100 (-0.52%)
PACX : 9.88 (+0.10%)
SNX : 118.33 (+1.04%)
XERS : 3.27 (-2.68%)
SBBP : 2.51 (-3.46%)
Enveric Biosciences and MagicMed to Participate in June 2021 Investor and Industry Conferences

, /PRNewswire/ --  (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel naturally occurring medicines to improve quality of life for cancer patients, and...

ENVB : 1.9100 (-0.52%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates CLDR, FMBI, ENVB, HRVSF; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CLDR : 15.86 (+0.25%)
FMBI : 17.97 (+0.73%)
ENVB : 1.9100 (-0.52%)
HRVSF : 3.5800 (-1.65%)
ENVERIC BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Enveric Biosciences, Inc. - ENVB

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of MagicMed Industries Inc. to Enveric Biosciences,...

ENVB : 1.9100 (-0.52%)
Enveric Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Enveric Biosciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - ENVB

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Enveric Biosciences, Inc. (NASDAQ: ENVB) and MagicMed Industries Inc. is fair to Enveric shareholders. Under...

ENVB : 1.9100 (-0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Enveric Biosciences Inc. is a patient-centric biotechnology company endeavoring to enhance the lives of Cancer Treatments with novel cannabinoid medicines. Enveric Biosciences Inc., formerly known as AMERI Holdings Inc., is based in NAPLES, Fla.

See More

Key Turning Points

3rd Resistance Point 2.0233
2nd Resistance Point 1.9967
1st Resistance Point 1.9533
Last Price 1.9100
1st Support Level 1.8833
2nd Support Level 1.8567
3rd Support Level 1.8133

See More

52-Week High 15.0400
Fibonacci 61.8% 9.9861
Fibonacci 50% 8.4250
Fibonacci 38.2% 6.8639
Last Price 1.9100
52-Week Low 1.8100

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar